Natural killer cell activity, lymphocyte proliferation, and cytokine profile in tumor-bearing mice treated with MAPA, a magnesium aggregated polymer from Aspergillus oryzae

Immunopharmacology and Immunotoxicology

Volumn 25, Issue 3, 2003, Pages 305-319

  Justo, G Z ^a   Duran N ^a   Queiroz, Mary L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Ehrlich tumor; IL 2; IL 4; INF ; MAPA; NK cell activity; Proteic aggregated polymer of magnesium ammonium phospholinoleate palmitoleate anhydride

Indexed keywords

ANTINEOPLASTIC AGENT; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MAGNESIUM AMMONIUM PHOSPHOLINOLEATE PALMITOLEATE ANHYDRIDE; MAGNESIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS ORYZAE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EHRLICH ASCITES TUMOR; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SPLENOMEGALY; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; ASPERGILLUS ORYZAE; CARCINOMA, EHRLICH TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CONCANAVALIN A; CYTOKINES; KILLER CELLS, NATURAL; LINOLEIC ACIDS; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; MITOGENS; ORGANOPHOSPHORUS COMPOUNDS; SPLEEN; SPLENOMEGALY; TIME FACTORS; TUMOR ESCAPE;

ANIMALIA; ASPERGILLUS; ASPERGILLUS ORYZAE;

EID: 0141453222     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120024499     Document Type: Article

References (49)

1. Chattopadhyay, U.; Bhattacharyya, S.; Chakrabarty, N.G. Tumor associated macrophage mediated lysis of autologous tumor cells. Neoplasma 1986, 33, 157.
2. Nelson, D.S.; Nelson, M. Evasion of host defenses by tumor. Immunol. Cell Biol. 1987, 65, 287.
3. Parhar, R.S.; Lala, P.K. Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance. Cell. Immunol. 1985, 93, 250.
4. 2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. J. Leukocyte Biol. 1988, 44, 185.
5. Lopez, D.M.; Lopez-Cepero, M.; Watson, G.A.; Ganju, A.; Sotomayor, E.M.; Fu, Y-X. Modulation of the immune system by mammary tumor-derived factors. Cancer Invest. 1991, 9, 643.
6. Arteaga, C.L.; Hurd, S.D.; Winnier, A.R.; Johnson, M.D.; Fendly, B.M.; Forbes, J.T. Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression. J. Clin. Invest. 1993, 92, 2569.
7. Gosh, P.; Komschlies, K.L.; Cippitelli, M.; Longo, D.L.; Subleski, J.; Ye, J.; Sica, A.; Young, H.A.; Wiltrout, R.H.; Ochoa, A.C. Loss of T-helper 1 populations in spleen of mice during progressive tumor growth. J. Natl. Cancer Inst. 1995, 87, 1478.
8. Handel-Fernandez, M.E.; Cheng, X.; Herbert, L.M.; Lopez, D.M. Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-γ production in mammary tumor-bearing mice. J. Immunol. 1997, 158, 280.
9. 2 enhanced peripheral blood lymphocyte IL-10 transcription and protein production. J. Immunol. 1995, 157, 5512.
10. Ruiz de Morales, J.; Vélez, D.; Subiza, J.L. Ehrlich tumor stimulates extramedullar hematopoiesis in mice without secreting identifiable colony-stimulating factors and without engagement of host T cells. Exp. Hematol. 1999, 27, 1757.
11. Segura, J.A.; Barbero, L.G.; Márquez, J. Early tumor effect on splenic Th lymphocytes in mice. FEBS Lett. 1997, 414, 1.
12. Subiza, J.L.; Viñuela, J.E.; Rodriguez, R.; Gil, J.; Figueredo, M.A.; De la Concha, E.G. Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice. Int. J. Cancer 1989, 44, 307.
13. Parhar, R.S.; Lala, P.K. Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity. Cell. Immunol. 1985, 93, 265.
14. 2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin-2 production and down regulation of transferrin receptor expression. J. Immunol. 1985, 135, 1172.
15. Segura, J.A.; Barbero, L.G.; Márquez, J. Ehrlich ascites tumor unbalances splenic cell populations and reduces responsiveness of T cells to Staphylococcus aureus enterotoxin B stimulation. Immunol. Lett. 2000, 74, 111.
16. Durán, N.; Nunes, O.D.S. Characterization of an aggregated polymer from Penicillium sp. (PB-73 strain). Brazil. J. Med. Biol. Res. 1990, 23, 1289.
17. Durán, N.; Haun, M.; Pereira-da-Silva, L.; Pisani, R.; Pisani, F.J.C.; Souza-Brito, A.R.M.; Mazetto, M.N.; Nunes, O.D.S. Comparison of the antiviral activity and toxicity of the protein magnesium ammonium phospholinoleate anhydride polymer with other antiviral drugs. Brazil. J. Med. Biol. Res. 1990, 23, 1303.
18. Durán, N.; Souza-Brito, A.R.M.; Haun, M.; De Oliveira, J.A.; Hetem, S.; Vargas, L.; Saavedra, I.; Justo, G.Z. SB-73-immunostimulant. Drugs Fut. 1993, 18, 327.
19. Durán, N.; Justo, G.Z.; Souza-Brito, A.R.M.; Rettori, O.; Vieira-Matos, A.N. SB-73/MAPA: Protein magnesium ammonium phospholinoleate-palmitoleate anhydride. Drugs Fut. 1997, 22, 454.
20. Melo, A.; Justo, G.Z.; Queiroz, M.L.S. Stimulation of myelopoiesis in Listeria monocytogenes-infected mice by an aggregated polymer isolated from Aspergillus oryzae. Human Exp. Toxicol. 2001, 20, 38.
21. Durán, N.; Justo, G.Z.; Queiroz, M.L.S.; Vieira-Matos, A.N.; Rettori, O. New perspectives in immunomodulatory therapy of tumor induced by an extracellular aggregated polymer isolated from Aspergillus oryzae. Int. J. Mol. Med. 1999, 4, S49.
22. Justo, G.Z.; Durán, N.; Queiroz, M.L.S. Myelopoietic response in tumor-bearing mice by an aggregated polymer isolated from Aspergillus oryzae. Eur. J. Pharmacol. 2000, 388, 219.
23. Olfert, E.D.; Cross, B.M.; McWilliam, A.A. In Guide to the Care and Use of Experimental Animals; Canadian Council on Animal Care: Ottawa, 1993; Vol. 1, 1.
24. Viñuela, J.E.; Rodríguez, R.; Gil, J.; Coll, J.; De la Concha, E.G.; Subiza, J.L. Antigen shedding vs. development of natural suppressor cells as mechanism of tumor escape in mice bearing Ehrlich tumor. Int. J. Cancer 1991, 47, 86.
25. Kim, S.; Iizuka, K.; Aguila, H.L.; Weissman, I.L.; Yokoyama, W.M. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc. Natl. Acad. Sci. USA 2000, 97, 2731.
26. Trinchieri, G. Biology of natural killer cells. Adv. Immunol. 1989, 47, 187.
27. Scott, P.; Trinchieri, G. The role of natural killer cells in host-parasite interactions. Curr. Opin. Immunol. 1995, 7, 34.
28. Djeu, J.Y.; Heinbaugh, J.A.; Holden, H.T.; Herberman, R.B. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J. Immunol. 1979, 122, 175.
29. Kuribayashi, K.; Gillis, S.; Kern, D.E.; Henney, C.S. Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J. Immunol. 1981, 126, 2321.
30. Malkovsky, M.; Loveland, M.; North, M.; Asherson, G.; Gao, L.; Ward, P.; Fiers, W. Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature 1987, 325, 262.
31. Pace, J.L.; Russel, S.W.; Torres, B.A.; Johnson, H.M.; Gray, P.W. Recombinant mouse γ interferon induces the priming step in macrophage activation for tumor cell killing. J. Immunol. 1983, 130, 2011.
32. Yamamoto, N.; Zou, J.P.; Li, X.F.; Takenaka, H.; Noda, S.; Fujii, T.; Ono, S.; Kobayashi, Y.; Mukaida, N.; Matsushima, K.; Fujiwara, H.; Hamaoka, T. Regulatory mechanisms for production of IFN-γ and TNF by antitumor T-cells or macrophages in the tumor-bearing state. J. Immunol. 1995, 154, 2281.
33. Hefeneider, S.H.; Conlon, P.J.; Henney, C.S.; Gillis, S. In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J. Immunol. 1983, 130, 222.
34. Henney, C.S.; Kuribayashi, K.; Kern, D.E.; Gillis, S. Interleukin-2 augments natural killer cell activity. Nature 1981, 291, 335.
35. + cells in mice. Int. J. Immunopharmacol. 2000, 22, 967.
36. Sayers, T.J.; Wiltrout, R.H. Differing roles for interleukin 2 and interferon γ in the augmentation of mouse peritoneal natural killer cell activity in vivo. In Natural Killer Cells and Host Defenses; Ades, E.W., Lopez, C., Eds.; S. Karger: AG, Basel, 1989; 88.
37. Young, H.A.; Ortaldo, J.R. One-signal requirement for interferon-γ production by human large granular lymphocytes. J. Immunol. 1987, 139, 724.
38. Allavena, P.; Scala, G.; Djeu, J.Y.; Procopio, A.D.; Oppenheim, J.S.; Herberman, R.B.; Ortaldo, J.R. Production of multiple cytokines by clones of human large granular lymphocytes. Cancer Immunol. Immunother. 1985, 19, 121.
39. Svedersky, L.P.; Nedwin, G.E.; Goeddel, D.V.; and Palladino, M.A., Jr. Interferon-γ enhances induction of lymphotoxin in recombinant interleukin 2-stimulated peripheral blood mononuclear cells. J. Immunol. 1985, 134, 1604.
40. Ehrhardt, R.O.; Ludviksson, B.R.; Gray, B.; Neurath, M.; Strober, W. Induction and prevention of chronic inflammation in IL-2-deficient mice. J. Immunol. 1997, 158, 566.
41. Taniguchi, T.; Matsui, H.; Fujita, T.; Takaoka, C.; Kashima, N.; Yoshimoto, R.; Hamuro, J. Structure and expression of cloned cDNA for human interleukin-2. Nature 1983, 302, 305.
42. Licastro, F.; Davis, L.J.; Morini, M.C. Lectins and superantigens: membrane interactions of these compounds with T lymphocytes affect immune responses. Int. J. Biochem. 1993, 25, 845.
43. Elexpuru, A.; Martin-Nieto, J.; Jimenez, A.; Gomez, C.; Villalobo, A. Ehrlich ascites tumor cells produce a transforming growth factor-beta (TGFβ)-like activity but lack receptors with TGFβ-binding capacity. Mol. Cell. Biochem. 1997, 170, 153.
44. + T cells is associated with decreased Th1 cytokine production in mice with plasma cell tumors. Tumori 1996, 82, 22.
45. Tada, T.; Ohzeki, S.; Utsumi, K.; Takiuchi, H., Muramatsu, M.; Li, X.-F. ; Shimizu, J.; Fujiwara, H.; Hamaoka, T. Transforming growth factor-β-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J. Immunol. 1991, 146, 1077.
46. + T cell clones and peripheral blood T cells. J. Immunol. 1992, 149, 2378.
47. Howard, M.; O'Garra, A. Biological properties of interleukin 10. Immunol. Today 1992, 13, 198.
48. Mehrotra, P.T.; Donnelly, R.P.; Wong, S.; Kanegane, H.; Geremew, A.; Mostowski, H.S.; Furuke, K.; Siegel, J.P.; Bloom, E.T. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J. Immunol. 1998, 160, 2637.
49. Ding, L.; Shevach, E.M. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 1992, 148, 3133.